Aptiom (eslicarbazepine acetate)

pCPA File Number: 20853

Negotiation Status:

Concluded with an LOI

Indication(s):

Epilepsy, partial-onset seizures

Sponsor/Manufacturer:

Sunovion Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0391-000

pCPA Engagement Letter Issued:

2015-06-15

Negotiation Process Concluded:

2015-09-08